Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).

Ryu, M-H

Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS). [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Oct 2015 - 2097-101 p. digital

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1569-8041

10.1093/annonc/mdv316 doi


Adenocarcinoma--drug therapy
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cisplatin--administration & dosage
Drug Administration Schedule
Drug Combinations
Follow-Up Studies
Humans
Lymphatic Metastasis
Neoplasm Recurrence, Local--drug therapy
Neoplasm Staging
Oxonic Acid--administration & dosage
Prognosis
Stomach Neoplasms--drug therapy
Survival Rate
Tegafur--administration & dosage